Advances in the pathogenesis of inflammatory bowel disease
- 86 Downloads
Most people do not develop inflammatory bowel disease (IBD) in spite of the density of the commensal flora. In the past few years, several areas of gut mucosal immunology have emerged that will permit advances in the management of IBD at the bedside. The commensal flora is only beginning to be fully appreciated as another metabolic organ in the body. Innate immunity as it relates to the gut has complemented our understanding of the adaptive immune response. The most important susceptibility gene described for Crohn’s disease, the NOD2 gene, participates in the innate immune response to pathogens. Patients carrying NOD2 mutations have an increased adaptive immune response to commensal organisms as measured by higher titers of antimicrobial antibodies, such as anti-CBir and anti-Saccharomyces cerevisiae antibodies. Toll-like receptors expressed by antigen-presenting cells (APCs) in the gut and intestinal epithelial cells also play a role in recognition of intestinal flora. Within the APC category, dendritic cells link the innate and adaptive immune systems and shape the nature of the adaptive immune response to commensal bacteria. With respect to adaptive immunity, a new signaling pathway involving a distinct helper CD4 T-cell subset producing interleukin-17 may become a target for the treatment of chronic inflammatory diseases. This review focuses on developments likely to culminate in advances in patient care.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 2.Sonnenburg JL, Xu J, Leip DD, et al.: Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 2005, 307:1955–1959. Germ-free mice were fed Bacteroides thetaiotaomicron. Depending on the available food source, B. thetaiotaomicron displayed flexible foraging behavior that contributed to ecosystem stability and functional diversity.PubMedCrossRefGoogle Scholar
- 17.Kobayashi KS, Chamaillard M, Ogura Y, et al.: Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005, 307:731–734. The role of NOD2 was studied in NOD2 -/- mice, which showed increased susceptibility to Listeria monocytogenes infection mediated through Paneth cells.PubMedCrossRefGoogle Scholar
- 28.Niess JH, Brand S, Gu X, et al.: CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 2005, 307:254–258. Lamina propria dendritic cells depend on the chemokine receptor CX3CR1 to form transepithelial dendrites. These projections control host interactions with commensal and pathogenic bacteria.PubMedCrossRefGoogle Scholar
- 42.Yen D, Cheung J, Scheerens H, et al.: IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 2006, 116:1310–1316. With the use of IL-23p19 null and IL-12p35 null mice, the investigators demonstrate that IL-23 but not IL-12 is essential for the development of intestinal inflammation.PubMedCrossRefGoogle Scholar
- 47.Kraus TA, Toy L, Chan L, et al.: Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease. Gastroenterology 2004, 126:1771–1778. This is the first study to test whether development of oral tolerance is impaired in patients with IBD. One group of investigators has explored the use of colon protein antigens in patients with CD to induce oral tolerance. The findings of this paper make it unlikely that oral tolerance strategies would be effective in IBD.PubMedCrossRefGoogle Scholar